NASDAQ:BRNS | Cash Flow Statement | Barinthus Biotherapeutics plc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$10.58M
2026-03-31-$5.53M$856,000.00-$3.37M$0.00$55,000.00$0.00
2025-12-31-$11.09M$909,000.00-$4.24M$0.00$2,000.00$0.00
2025-09-30-$14.57M
2025-06-30-$21.12M
2025-03-31-$19.65M$2.03M-$14.9M$5,000.00-$5,000.00$2,000.00
2024-12-31-$20.54M$1.43M$13.09M$278,000.00-$278,000.00$837,000.00
2024-09-30-$8.11M
2024-06-30-$16.93M
2024-03-31-$15.49M$1.43M-$11.82M$308,000.00-$308,000.00$503,000.00
2023-12-31-$17.29M$1.44M-$19.6M-$153,000.00$153,000.00$109,000.00
2023-09-30-$14.07M
2023-06-30-$23.8M
2023-03-31-$18.18M$1.22M-$3.17M$2.51M-$2.51M$1.69M
2022-12-31-$21.19M$1.18M-$11.34M$586,000.00-$586,000.00$484,000.00
2022-09-30$8.24M
2022-06-30$15.69M
2022-03-31$2.6M$966,000.00-$6.58M$1.09M-$1.09M-$159,000.00
2021-12-31-$15.11M$321,000.00-$7.97M$424,000.00-$12.19M$9,000.00
2021-09-30-$4.56M
2021-06-30-$15.93M
2021-03-31-$15.27M$92,000.00-$7.97M$392,000.00-$392,000.00$121.82M
2020-12-31-$10.46M$56,000.00-$4.9M$195,000.00-$195,000.00$16.48M
2020-09-30$158,000.00
2020-06-30-$3.59M
2020-03-31-$3.82M$49,000.00-$4.32M$22,000.00-$22,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$66.43M$5.85M-$47.98M$37,000.00$416,000.00$2,000.00
2024-12-31-$61.07M$5.8M-$28.94M$892,000.00-$892,000.00$2.16M
2023-12-31-$73.35M$5.43M-$50.93M$5.41M-$5.41M$1.87M
2022-12-31$5.34M$4.32M-$14.43M$6.14M-$5.75M$325,000.00
2021-12-31-$50.87M$602,000.00-$32.58M$1.15M-$12.91M$222.74M
2020-12-31-$17.71M$208,000.00-$11.03M$293,000.00-$293,000.00$41.44M